Anti-EBOV GP Neutralizing Antibody (V3S-0723-FY132) (CAT#: V3S-0723-FY132)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description mAb 2G1 showed a broad cross-reactivity to different ebolavirus GPs, including EBOV, SUDV, BDBV, and RESTV. The EC50 values for mAb 2G1 against these GPs were 8.7, 9.7, 24.1, and 65.8 ng/mL, respectively.
Clonality Monoclonal
Host Species Human
Target Species Ebola Virus (EBOV)
Isotype IgG

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; WB; Neut
Application Notes The EC50 values for mAb 2G1 against GPs of EBOV, SUDV, BDBV, and RESTV were 8.7, 9.7, 24.1, and 65.8 ng/mL, respectively.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target EBOV GP
Alternative Name Ebola virus; EBOV
Research Area Microbiology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry